Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Waldenstrom's Macroglobulinemia
NCT00083707Phase 2Completed
- Sponsor
- University of Arkansas
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in Waldenstrom macroglobulinemia (WM), sponsored by University of Arkansas. Started Jan 1999; status: completed.
02
Drugs
thalidomide
03
Conditions
Waldenstrom macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00083707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083707.